DRUG STUDY Generic Classification and Brand Name GENERI amide type local C anaesthetic NAME: Bupivacai ne HCL

BRAND NAME: Sensorcai ne, Marcaine Dosage/Stock Dose 175mg. Nursing Considerati ons For the Sensorcaine Excessive When Blocks plasma appropriate, reuptake of production of (bupivacaine local or HCl) is concentration patients neurotrans regional contraindicated of the local should be mitters anesthesia or in obstetrical anesthetic informed in (serotonin, analgesia for paracervical advance that norepinep surgery, for block they may hrine) at oral surgery anesthesia. Its experience CNS procedures, use by this temporary presynapti for technique has loss of c diagnostic resulted in fetal sensation membrane and bradycardia and and motor s, therapeutic death. activity, increasing procedures, usually in availability and for the lower Sensorcaine is at contraindicated obstetrical half of the postsynapti procedures. body in patients with a known following c receptor proper hypersensitivity sites. to it or to any administrati Reduces on of caudal local anesthetic firing rate agent of the or lumbar of epidural amide type or to noradrener other anesthesia. gic Also, when components of neurons, bupivacaine appropriate, eliminating the solutions. nicotine physician withdrawal Action Indication Contraindicatio n Side Effects

symptoms.

should discuss other information including adverse reactions in the Sensorcaine package insert. Inform the patient before using this medication, to tell his/her doctor or pharmacist of all prescription and nonprescript ion/herbal products he/she may use. Do not start or stop any medicine without

doctor or pharmacist approval.

DRUG STUDY Generic Classification and Brand Name Nalbuphin Opioid agonistantagonist analgesic e HCL Dosage /Stock Dose Action Indication Contraindicatio n Hypersensitivit y to nalbuphine or any component, including sulfites; pregnancy (prolonged use or high dosages at term) Side Effects Nursing Considerati ons Taper dosage when discontinuin g after prolonged use to avoid withdrawal symptoms. Keep opioids antagonist and facilities for assisted or controlled respiration readily available in case of respiratory

CNS effects: Nervousness, depression, restlessness, crying, euphoria, floating, hostility, unusual dreams, confusion, faintness, hallucination s, dysphoria, feeling of heaviness, numbness, tingling, unreality. The incidence of psychotomim eti

c effects, such as unreality, depersonaliza ti on, delusions, dysphoria and hallucination s has been shown to be less than that which occurs with pentazocine.

depression. Reassure patient about addiction liability; most

patients who receive opiates for medical reasons do not Cardiovascu develop dependence lar: Hypertension syndrome , hypotension, bradycardia, tachycardia, pulmonary edema. Gastrointesti nal: Cramps, dyspepsia,

bitter taste. Respiration: Depression, dyspnea, asthma. Dermatologi cal: Itching, burning, urticaria

DRUG STUDY Generic and Brand Name Classification Dosage /Stock Dose Action Indication Contraindicatio n Side Effects Nursing Consideration s